Related Experiment Video
Updated: Mar 1, 2026
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
17.2K
A GEMA of a personalized medicine strategy
1Department of Radiation Oncology and the Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43017, USA.
Science Translational Medicine
|May 26, 2017
Abstract:
A screening method can identify tumors susceptible to synthetic lethality via PARP inhibition.
Insights
A new screening method identifies tumors that respond to synthetic lethality by targeting poly (ADP-ribose) polymerase (PARP) inhibition. This approach aids in precision medicine for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Synthetic lethality is a promising strategy in cancer therapy.
- Poly (ADP-ribose) polymerase (PARP) inhibitors are effective against tumors with DNA repair deficiencies.
- Identifying predictive biomarkers for PARP inhibitor response is crucial.
Purpose of the Study:
- To develop and validate a screening method for predicting synthetic lethality via PARP inhibition.
- To identify specific tumor types or genetic profiles susceptible to this therapeutic approach.
Main Methods:
- Development of a high-throughput screening assay.
- Utilizing cell lines with defined DNA repair pathways.
- Assessing cell viability and DNA damage response post-PARP inhibition.
Main Results:
- The screening method successfully identified known PARP inhibitor-sensitive and resistant tumor models.
- Specific genetic markers correlated with sensitivity to PARP inhibition were elucidated.
- Demonstrated the feasibility of predicting therapeutic response.
Conclusions:
- The developed screening method is a valuable tool for identifying tumors amenable to synthetic lethality with PARP inhibitors.
- This facilitates patient stratification for targeted cancer therapy.
- Supports the advancement of precision oncology strategies.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:29Pharmacogenetics and Pharmacogenomics: Overview
81
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
81
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:24Dosage Regimen: Individualization
232
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
232
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65